STEMLINE THERAPEUTICS INC — Operating Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/517af7c4-652b-461c-a88c-e3d1bbb01055/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2019 | $-79.2M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-034154 |
| FY 2018 | $-86.3M | 2018-01-01 – 2018-12-31 | evidence 0001104659-19-015293 |
| FY 2017 | $-68.6M | 2017-01-01 – 2017-12-31 | evidence 0001104659-18-018361 |
| FY 2016 | $-38.9M | 2016-01-01 – 2016-12-31 | evidence 0001104659-17-017199 |
| FY 2015 | $-37.6M | 2015-01-01 – 2015-12-31 | evidence 0001104659-16-104922 |
| FY 2014 | $-29.0M | 2014-01-01 – 2014-12-31 | evidence 0001104659-15-020076 |
| FY 2013 | $-53.9M | 2003-08-08 – 2014-03-31 | evidence 0001104659-14-039365 |
| FY 2012 | $-26.3M | 2003-08-08 – 2013-03-31 | evidence 0001104659-13-048660 |
| FY 2011 | $-2.7M | 2011-01-01 – 2011-12-31 | evidence 0001104659-14-024493 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
STEMLINE THERAPEUTICS INC — all facts · Revenue · Net Income